Hyperion Therapeutics Investors

16 investors on Angel Roster list Hyperion Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, the Netherlands and Belgium.

Investors are matched on the company name in their portfolio, so companies that share the name Hyperion Therapeutics can appear together.

Investors listed
16
With verified email
25%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Hyperion Therapeutics investors

The most complete profiles first. Showing 16 of 16.

  • Audrey VallenVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceAd Targeting

    Portfolio: Tynt, CHiL Semiconductor, BelAir Networks, Hyperion Therapeutics and 25 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • Rod FergusonVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceAd Targeting

    Portfolio: Tynt, CHiL Semiconductor, BelAir Networks, Hyperion Therapeutics and 25 more

    Verified email available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Shahan Soghikian

    Venture Capital · United States

    AdvertisingHealth CareE-commerceAd Targeting

    Portfolio: Tynt, CHiL Semiconductor, BelAir Networks, Hyperion Therapeutics and 25 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Jake NunnVerified

    Venture Capital, Angel/Individual, Investor · United States

    Series BE-commerceWomen FoundedAppsArtificial Intelligence (AI)

    Portfolio: Dermira, TriVascular, Hyperion Therapeutics, Transcept Pharmaceuticals

    Verified email available

  • Dylan Bird

    Angel/Individual · United States

    Health CareEnterprise SoftwareMobileClean Technology

    Portfolio: Dermira, sunesis pharmaceutical, GenturaDx, Epizyme and 4 more

    Contact details available

  • Bijan Salehizadeh

    Venture Capital, Private Equity Firm · United States

    Health CareMedia and Entertainment

    Portfolio: Barrx Medical, Hyperion Therapeutics, OpGen, Lumere (formerly Procured Health) and 2 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Hyperion Therapeutics investors are on Angel Roster?

Angel Roster lists 16 Hyperion Therapeutics investors. 4 of them (25%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (13), Private Equity Firms (6) and Angel Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Hyperion Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (4) and Seed (1).

Where are Hyperion Therapeutics investors based?

Most are based in the United States (11), the Netherlands (3) and Belgium (1).

Which companies have Hyperion Therapeutics investors backed?

The most-backed portfolio companies among them are Merus (10), NextWave Pharmaceuticals (8), Presidio Pharmaceuticals (8), Dermira (7) and Ion Torrent (6).

How do I contact Hyperion Therapeutics investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.